Latest Insider Transactions at Acer Therapeutics Inc. (ACER)
This section provides a real-time view of insider transactions for Acer Therapeutics Inc. (ACER). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Acer Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Acer Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
Steve Aselage Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
483,741
-100.0%
|
-
|
|
Nov 17
2023
|
Donald Joseph Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,285
-100.0%
|
-
|
|
Nov 17
2023
|
John Michael Dunn Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,380
-100.0%
|
-
|
|
Nov 17
2023
|
Jefferson E Davis CHIEF BUSINESS OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
71,645
-100.0%
|
-
|
|
Nov 17
2023
|
Harry S Palmin CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
125,000
-100.0%
|
-
|
|
Nov 17
2023
|
Chris Schelling PRESIDENT AND CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,712,529
-100.0%
|
-
|
|
Nov 29
2022
|
Steve Aselage Director |
BUY
Open market or private purchase
|
Direct |
409,836
+45.86%
|
$409,836
$1.22 P/Share
|
|
Nov 29
2022
|
Chris Schelling PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
819,672
+23.21%
|
$819,672
$1.22 P/Share
|
|
Dec 10
2021
|
Steve Aselage Director |
BUY
Open market or private purchase
|
Direct |
7,984
+9.75%
|
$15,968
$2.04 P/Share
|
|
Dec 09
2021
|
Steve Aselage Director |
BUY
Open market or private purchase
|
Direct |
2,016
+2.97%
|
$4,032
$2.15 P/Share
|